Why Clovis Oncology Shares Got a Bump This Week

[cafead]

via

• Clovis may be benefitting from a short-squeeze effort by retail investors.
• The jump was surprising considering the company’s disappointing second-quarter numbers.
• The company has one marketed drug, Rubraca.

article source